Why the study?
The study aimed to assess CMR-derived myocardial deformation in autoimmune rheumatic diseases while distinguishing cohorts with documented absence of clinically overt cardiac involvement from incompletely documented and broader clinical populations.
Population
73 reports in 48 cohort families of patients with autoimmune rheumatic diseases and controls
Comparison
Patients with autoimmune rheumatic diseases vs controls
Design
Systematic review and random-effects meta-analysis
Answers are grounded in this paper and cite their sources.
Very low-certainty evidence precludes practice change; leaves open GLS prognostic value in autoimmune cohorts without overt cardiac disease.
Background/Objectives: We assessed cardiovascular magnetic resonance (CMR)-derived myocardial deformation in autoimmune rheumatic diseases (ARDs), distinguishing cohorts with documented absence of clinically overt cardiac involvement from incompletely documented and broader clinical populations. Methods: The original searches of PubMed, Embase, Scopus, and CENTRAL were performed on 2 September 2026. Web of Science and supplementary citation searching were added during revision, with final search exports dated 27 October 2026. Principal random-effects analyses used cohorts with documented target phenotypes and direct mean/SD data, restricted maximum likelihood estimation and ordinary Hartung–Knapp inference; modified Hartung–Knapp inference was examined as a sensitivity analysis. Critical appraisal used JBI tools and certainty was assessed using GRADE. PROSPERO: CRD420261495586. Results: We retained 73 reports in 48 cohort families. In the principal GLS analysis, five comparisons involving 168 patients and 130 controls gave a mean difference of 2.46 percentage points (95% CI 0.82 to 4.11), indicating less negative GLS in the disease groups. The 95% prediction interval included zero (−1.33 to 6.26). The confidence intervals for global circumferential and radial strain included differences in both directions. Evidence certainty was very low for all three outcomes. Conclusions: The pooled GLS estimate suggested a smaller magnitude of longitudinal shortening in patients with autoimmune rheumatic diseases without established clinically overt cardiac disease, but the evidence was very uncertain. The evidence for circumferential and radial strain was also very uncertain.
No takes yet. Share an insight, caveat, or question.
Arnăutu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: